DCF — QUEEN OF THE VALLEY MEDICAL CENTER
Enterprise Value: $-739.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-739.1M
Enterprise Value
$-228.4M
PV of Cash Flows
$-510.6M
PV of Terminal Value
$-822.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $302.6M | $-49.0M | -16.0% | $-61.8M | $-56.2M |
| Year 2 | $311.7M | $-47.3M | -15.0% | $-60.5M | $-50.0M |
| Year 3 | $321.1M | $-45.5M | -14.0% | $-59.1M | $-44.4M |
| Year 4 | $330.7M | $-45.3M | -14.0% | $-59.2M | $-40.5M |
| Year 5 | $340.6M | $-45.8M | -13.0% | $-60.2M | $-37.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-739.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$293.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16683842767404103
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5